Healthy Clinical Trial
Official title:
Blood Glucose Monitoring, Cognition, and Wellbeing in Relation to Food Intake @ Work - a Pilot Study
NCT number | NCT03295578 |
Other study ID # | P9663 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 2, 2017 |
Est. completion date | December 22, 2017 |
Verified date | March 2020 |
Source | TNO |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This randomized controlled pilot study has as a main aim to investigate the relationship
between glucose and cognition and wellbeing, as well as food intake in an at-work setting.
Additionally, the continuous glucose data collected in the study will be used to investigate
the inter- and intraindividual variability in glucose response to foods/meal in a real-life
setting.
Finally, the study aims to determine if self-monitoring and feedback about food intake and
health stimulate individuals to make healthier choices.
This study will have two groups, the feedback group and the control group. The study will
consist of two self-monitoring periods of two weeks. In between these two self-monitoring
periods, the participants in the feedback group will be given feedback on their measurement
data. The control group will not get any feedback.
Status | Completed |
Enrollment | 45 |
Est. completion date | December 22, 2017 |
Est. primary completion date | November 17, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 67 Years |
Eligibility |
Inclusion Criteria: - Must be present at Jumbo head-quarters during lunch at least four days/week and have access to their computer for one hour after lunch during the two 2-week self-monitoring periods - Must be frequent visitors of the company lunch restaurant (Jumbo food café), with a minimum of three times per week - Having giving written informed consent - Willing to comply with all study procedures Exclusion Criteria: - Shift workers - Diabetes type 2 patients - Under treatment for neurological or psychiatric complaints, including eating disorders - Specific dietary preferences, including vegan, raw food, paleo. Vegetarian, pescetarians and flexitarians can participate in the study - Allergies or intolerances, including coeliac disease, gluten intolerance, lactose intolerance, milk protein allergy - Skin allergy or eczema |
Country | Name | City | State |
---|---|---|---|
Netherlands | Jumbo Supermarkten BV. | Veghel | Noord-Brabant |
Lead Sponsor | Collaborator |
---|---|
TNO | Google Inc., Jumbo Supermarkten Bv., Noldus Information Technology B.V., Wageningen University and Research |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Focus on future consequences | validated questionnaire from Joireman et al (2012). Output will be used as input for formulating the personalized feedback | baseline | |
Other | Subjective health | • Subjective health is measured with two items that are rated on seven-point scales from 'very unhealthy' (1) to 'very healthy' (7). | Baseline and after eight weeks (end of study) | |
Other | Eating habits (at the workplace) | mapped via a questionnaire, concerning how often one eats breakfast and snacks, how often one eats in the company restaurant at work, how often one brings their own lunch or buys their lunch, how often one goes on lunch walks etc. | Baseline and after eight weeks (end of study) | |
Other | Physical activity | the Dutch Norm for Healthy Physical Activity. | Baseline and after eight weeks (end of study) | |
Other | BMI | calculated based on self-reported height and weight | Baseline and after eight weeks (end of study) | |
Primary | Daily glucose levels | measured using a continuous glucose monitoring device | Continous (sampled every 15 minutes for a duration of 14 days) | |
Primary | Daily food intake | measured using a food intake application | daily registration of food intake during working hours for a duration of 14 days (during both the two week measurement periods).. | |
Primary | Cognition tests | via Smartphone application. Tests include direct recall, free recall & delayed recall. | twice per day (before and after lunch) at working days for a duration of 14 days, during both the two week measurement periods | |
Primary | Wellbeing | via Smartphone application. Includes VAS scales for including five questions for 'feeling energetic - tired, 'feeling focused - distracted', 'feeling positive - negative' , 'feeling motivated - unmotivated' , 'feeling relaxed - stressed' | This questionnaire will be administered five times per day; two times in the morning, once five minutes before lunch (before with cognition test), once one hour after lunch (before cognition test) and once in the afternoon for two times 14 days. | |
Secondary | Intention to eat healthy | measured with three items on seven-point scales from totally disagree (1) to totally agree (7). The items are 'I'm planning on eating healthy', 'I would consider to eat healthy' and 'I'm absolutely going to eat healthy'. | baseline and after eight weeks (end of study) | |
Secondary | Quantitative user experiences | Self-efficacy towards maintaining a healthy diet and type of motivation to eat healthy | baseline and after eight weeks (end of study) | |
Secondary | Qualitative user experiences | the survey includes self-constructed scales that measure user experience with the research in general, self-monitoring devices and personal feedback. Focus groups are needed to understand the reasoning behind the answers that employees give in the surveys and to validate initial analysis of the survey. | four short surveys (baseline, day 1, after two weeks, after eight weeks) and in focus groups after eight weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |